Record Date Set for Extraordinary General Meeting... Routine Procedural Disclosure

Y-Biologics set June 11, 2026 as the record date to determine shareholders entitled to vote at the extraordinary general meeting
No book-closure period was set, and the board resolution date is May 27, 2026
This is a routine procedural disclosure regarding the closure of the shareholder register and setting of a record date, with no direct impact on shareholder value
[AI Comprehensive Analysis]This disclosure is merely a procedural step to determine voting rights, a neutral event that cannot be classified as positive or negative. It has no impact on stock price or enterprise value.